Thiothixene Hydrochloride

Sold as Navane. Every FDA application for this active ingredient: 2 branded and 6 generic.

As of Nov 15, 2026, FDA lists 8 applications for Thiothixene Hydrochloride (sold as Navane), first approved Apr 6, 1970, with 0 new uses approved and 0 published complete response letters.

First approved: Apr 6, 1970
Applications: 8
New uses approved: 0
Complete response letters: 0

What Pharmacies Pay

Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change

THIOTHIXENE 1 MG CAPSULE: $0.653 per unitGeneric · -12% in a year
THIOTHIXENE 10 MG CAPSULE: $1.69 per unitGeneric · -3% in a year
THIOTHIXENE 2 MG CAPSULE: $0.815 per unitGeneric · -14% in a year
THIOTHIXENE 5 MG CAPSULE: $1.33 per unitGeneric · +0% in a year

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history


Apr 6, 1970	NavaneNDA 16758 · New active ingredient	Pfizer	7	Discontinued
Aug 19, 1971	NavaneNDA 16904 · New active ingredient	Pfizer	17	Discontinued
Jun 22, 1987	Thiothixene HydrochlorideANDA 71184	Teva	4	Discontinued
Oct 16, 1987	Thiothixene HydrochlorideANDA 71554	Teva Pharms	14	Discontinued
—	Thiothixene HydrochlorideANDA 70969	Alpharma US Pharms	0	Discontinued
—	Thiothixene HydrochlorideANDA 71917	Paco	0	Discontinued
—	Thiothixene HydrochlorideANDA 71939	Paco	0	Discontinued
—	Thiothixene Hydrochloride IntensolANDA 73494	Hikma	0	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA